RESUMO
La Tracción vitreomacular (TVM) hace parte de un grupo de trastornos que se cree tienen una génesis similar, y teniendo en cuenta las variaciones de la terminología en la literatura, es fundamental tener claridad sobre los conceptos básicos, por tal motivo se realiza un artículo de revisión de literatura donde se describe la historia, definición, clasificación, asociaciones y nuevos tratamientos del síndrome de tracción vitreomacular en la actualidad.
The vitreomacular traction syndrome (VMT) is part of a wide group of retinal diseases with a similar thought etiology, and allowing for the similar terminology used, is essential to be clear about concepts and basic notions; accordingly, this review article describes history, defi nition, classifi cation, associations and novel treatment for vitreomacular traction syndrome.
Assuntos
Humanos , Doenças Retinianas , Edema Macular , Tomografia de Coerência Óptica , VitrectomiaRESUMO
A 59-year-old Hispanic woman presented with a 3-year history of floaters associated with bilateral reduced visual acuity. Her best-corrected visual acuity (BCVA) was 20/40. Both anterior segments were without inflammation, but fundoscopy showed mild vitreous inflammation and multiple inflammatory choroidal lesions. Tests for inflammatory and infectious diseases were negative except for human leucocyte antigen A29. The patient was diagnosed with birdshot choroidoretinopathy, and treatment was initiated with cyclosporine A 2.5â mg/kg/day. One year after treatment, the patient reported systemic symptoms with no improvement in visual acuity. Fundus findings remained with vitreal inflammation. QuantiFERON-TB Gold In-Tube Test was positive, and a diagnosis of presumed latent ocular tuberculosis (TB) was made. We initiated anti-TB treatment for 9â months. At 6â months of anti-TB therapy, there was no active inflammation. The patient was followed for 2â years with no medications and no active inflammation. Her final BCVA was 20/25.